Research Progress of Neurogenic Exosomes in the Treatment of Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Advances in Clinical Medicine

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.12677/acm.2024.1492563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease

  2024cited by this paper
• Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of Alzheimer’s disease

  2024cited by this paper
• Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases

  2024cited by this paper
• Research progress in the mechanism of acupuncture regulating microglia in the treatment of Alzheimer’s disease

  2024cited by this paper
• Microglial extracellular vesicles induce Alzheimer’s disease-related cortico-hippocampal network dysfunction

  2023cited by this paper
• Transcriptome Analysis Unveils That Exosomes Derived from M1-Polarized Microglia Induce Ferroptosis of Neuronal Cells

  2022cited by this paper
• Conventional Versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist With Aducanumab

  2022cited by this paper
• Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs

  2022cited by this paper
• Multiple roles of neuronal extracellular vesicles in neurological disorders

  2022cited by this paper
• Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease

  2022cited by this paper
• The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease

  2022cited by this paper
• Glial Cells in Alzheimer's Disease: From Neuropathological Changes to Therapeutic Implications.

  2022cited by this paper
• Extracellular vesicles derived from astrocyte-treated with haFGF14-154 attenuate Alzheimer phenotype in AD mice

  2022cited by this paper
• NMDA and AMPA receptors dysregulation in Alzheimer's disease.

  2021cited by this paper
• Microglia extracellular vesicles: focus on molecular composition and biological function.

  2021cited by this paper
• A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice

  2021cited by this paper
• Extracellular Vesicles in neural cell interaction and CNS homeostasis

  2021cited by this paper
• 2021 Alzheimer's disease facts and figures

  2021cited by this paper
• The emerging role of exosomes in Alzheimer's disease.

  2021cited by this paper
• Clinicopathological concordance in cognitive disease diagnostics.

  2020cited by this paper
• Identifying brain functional connectivity alterations during different stages of Alzheimer’s disease

  2020cited by this paper
• Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease

  2020cited by this paper
• Stimulus‐dependent modifications in astrocyte‐derived extracellular vesicle cargo regulate neuronal excitability

  2020cited by this paper
• Protein transmission in neurodegenerative disease

  2020cited by this paper
• The biology, function, and biomedical applications of exosomes

  2020cited by this paper
• Apoptotic Bodies: Particular Extracellular Vesicles Involved in Intercellular Communication

  2020cited by this paper
• CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)G93A ALS mice originate from astrocytes and neurons and carry misfolded SOD1

  2019cited by this paper
• Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress

  2019cited by this paper
• Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases

  2019cited by this paper
• Neuroinflammation and Perioperative Neurocognitive Disorders

  2019cited by this paper
• The emerging role of exosomes in mental disorders

  2019cited by this paper
• Astrocyte morphology: Diversity, plasticity, and role in neurological diseases

  2019cited by this paper
• Microglia-mediated neuroinflammation in neurodegenerative diseases.

  2019cited by this paper
• Neuron-derived exosomes with high miR-21-5p expression promoted polarization of M1 microglia in culture.

  2019cited by this paper
• Increased miR‐124‐3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons

  2018cited by this paper
• The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer.

  2018cited by this paper
• Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

  2018cited by this paper
• Shedding light on the cell biology of extracellular vesicles

  2018cited by this paper
• VEGF Signaling in Neurological Disorders

  2018cited by this paper
• The release and trans-synaptic transmission of Tau via exosomes

  2017cited by this paper
• Current knowledge on exosome biogenesis and release

  2017cited by this paper
• Microglia Function in the Central Nervous System During Health and Neurodegeneration.

  2017cited by this paper
• Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model.

  2016cited by this paper
• Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases.

  2016cited by this paper
• Vascular endothelial growth factor: a neurovascular target in neurological diseases

  2016cited by this paper
• Exosomes in Alzheimer's disease.

  2016cited by this paper
• Physiological and pathological roles of exosomes in the nervous system

  2016cited by this paper
• Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges

  2016cited by this paper
• Endocytic pathways and endosomal trafficking: a primer

  2016cited by this paper
• Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice.

  2015cited by this paper
• Biological properties of extracellular vesicles and their physiological functions

  2015cited by this paper
• Thematic Minireview Series: Molecular Mechanisms of Synaptic Plasticity*

  2015cited by this paper
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation

  2015cited by this paper
• Emerging Roles of Extracellular Vesicles in the Nervous System

  2014cited by this paper
• Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration

  2013cited by this paper
• Extracellular vesicles: Exosomes, microvesicles, and friends

  2013cited by this paper
• Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity

  2012cited by this paper
• Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression.

  2012cited by this paper
• Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

  2010cited by this paper
• Endosome-lysosome fusion.

  2010cited by this paper
• Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele

  2005cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper

• Research Progress of Exosomes in the Treatment of Neurodegenerative Diseases

  2025cites this paper